Why Join Clinical Trials?

Yesterday's clinical trials are today's myeloma therapies. Whether you're newly diagnosed, have relapsed or refractory myeloma or are looking to a future of treatment with immunotherapies, joining a clinical trial offers early access to therapies that are changing the myeloma landscape. Patients can join clinical trials to gain access to the very latest myeloma therapies and receive attentive care during their participation. While you need to be in a clinical trial that is right for you, there are an incredible variety to choose from. So take a look today and plan ahead for your very best myeloma care .

Find a Myeloma Clinical Trial




What is Multiple Myeloma?

Multiple myeloma is a cancer of the blood and is caused by a change to the DNA of a single stem cell in the bone marrow. The bone marrow creates red blood cells, white blood cells and platelets and the white blood cells are responsible for creating antibodies that fight disease and infection. In myeloma, the B cells (or types of white blood cells) become cancerous and one type will start to overgrow, crowding out the normal antibodies.

Learn More